[{"id":"2333fc8d-28f2-4288-aae2-5611bad53f1d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01560949","created_at":"2021-01-18T06:36:46.022Z","updated_at":"2024-07-02T16:36:42.183Z","phase":"Phase 2","brief_title":"Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas","source_id_and_acronym":"NCT01560949","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" SMAD4","pipe":" | ","alterations":" SMAD4 positive","tags":["SMAD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SMAD4 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e gemcitabine • 5-fluorouracil • oxaliplatin • irinotecan • leucovorin calcium • fluorouracil topical"],"overall_status":"Completed","enrollment":" Enrollment 34","initiation":"Initiation: 06/14/2012","start_date":" 06/14/2012","primary_txt":" Primary completion: 02/20/2019","primary_completion_date":" 02/20/2019","study_txt":" Completion: 02/20/2019","study_completion_date":" 02/20/2019","last_update_posted":"2020-08-10"}]